logo
#

Latest news with #TRNS

Transcat to Host First Quarter Fiscal Year 2026 Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. Eastern Time
Transcat to Host First Quarter Fiscal Year 2026 Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. Eastern Time

Globe and Mail

time23-07-2025

  • Business
  • Globe and Mail

Transcat to Host First Quarter Fiscal Year 2026 Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. Eastern Time

Transcat, Inc. (Nasdaq: TRNS) ('Transcat' or the 'Company'), a leader in test measurement, control and calibration, announced that it will release its first quarter fiscal year 2026 results after the close of financial markets on Wednesday, August 6, 2025. The Company will host a conference call and webcast on Thursday, August 7, 2025 at 11:00 a.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow. First Quarter Fiscal Year 2026 Conference Call Thursday, August 7, 2025 11:00 a.m. Eastern Time Dial-in – Toll-Free US / Canada: (800) 267-6316 Dial-in – Toll / International: (203) 518-9783 Conference ID: TRANSCAT (THIS CONFERENCE ID WILL BE REQUIRED FOR ENTRY) Webcast and accompanying slide presentation: A telephonic replay will be available from 3:00 p.m. ET on the day of the conference call through Thursday, August 14, 2025. To listen to the archived call, dial (844) 512-2921 from the US or Canada, or (412) 317-6671 from international locations, and enter conference ID number 11159645 or access the webcast replay at where a transcript will be posted once available. About Transcat Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity creates a unique and compelling value proposition for its customers. Transcat's strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at:

Transcat (TRNS): Buy, Sell, or Hold Post Q4 Earnings?
Transcat (TRNS): Buy, Sell, or Hold Post Q4 Earnings?

Yahoo

time18-04-2025

  • Business
  • Yahoo

Transcat (TRNS): Buy, Sell, or Hold Post Q4 Earnings?

Transcat has gotten torched over the last six months - since October 2024, its stock price has dropped 35.3% to $84.55 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move. Following the pullback, is this a buying opportunity for TRNS? Find out in our full research report, it's free. Serving the pharmaceutical, industrial manufacturing, energy, and chemical process industries, Transcat (NASDAQ:TRNS) provides measurement instruments and supplies. A company's long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Thankfully, Transcat's 9.6% annualized revenue growth over the last five years was solid. Its growth beat the average industrials company and shows its offerings resonate with customers. We track the long-term change in earnings per share (EPS) because it highlights whether a company's growth is profitable. Transcat's EPS grew at a spectacular 17.1% compounded annual growth rate over the last five years, higher than its 9.6% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded. ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity). We like to invest in businesses with high returns, but the trend in a company's ROIC is what often surprises the market and moves the stock price. On average, Transcat's ROIC decreased by 3.8 percentage points annually over the last few years. If its returns keep falling, it could suggest its profitable growth opportunities are drying up. We'll keep a close eye. Transcat's merits more than compensate for its flaws. With the recent decline, the stock trades at 32.6× forward price-to-earnings (or $84.55 per share). Is now the time to initiate a position? See for yourself in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio

Transcat (TRNS) Fell on Disappointing Results
Transcat (TRNS) Fell on Disappointing Results

Yahoo

time10-04-2025

  • Business
  • Yahoo

Transcat (TRNS) Fell on Disappointing Results

Headwaters Capital Management, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Smaller businesses, which are thought to be more susceptible to economic downturns, faced a challenging combination of economic and policy uncertainties in the quarter. It was not unexpected that small-cap equities led the market lower given the economic conditions that prevailed in Q1. In this environment, the fund returned -9.0% (-9.2% net) in the quarter compared to a -3.4% return for the Russell Mid Cap Index. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first quarter 2025 investor letter, Headwaters Capital Management emphasized stocks such as Transcat, Inc. (NASDAQ:TRNS). Transcat, Inc. (NASDAQ:TRNS) offers calibration and laboratory instrument services. The one-month return of Transcat, Inc. (NASDAQ:TRNS) was 7.68%, and its shares lost 30.33% of their value over the last 52 weeks. On April 9, 2025, Transcat, Inc. (NASDAQ:TRNS) stock closed at $76.54 per share with a market capitalization of $690.48 million. Headwaters Capital Management stated the following regarding Transcat, Inc. (NASDAQ:TRNS) in its Q1 2025 investor letter: "Top Detractor: Transcat, Inc. (NASDAQ:TRNS) – 30%. TRNS delivered a disappointing quarter as results from their 2021 Nexa acquisition materially missed expectations. As a reminder, TRNS provides inspection and calibration services for test and measurement instruments in the life sciences and industrial industries. These calibration and testing services are highly regulated by governing bodies (FDA, etc) and are required to be performed on a regular schedule. NEXA provides more project-based consulting services and this part of NEXA's business saw a material decline in performance. Management appears to have ring fenced the issue and more importantly, the core calibration business for TRNS continues to perform well. Given the critical nature of Transcat's services, the continued trend toward outsourcing these services and ample M&A opportunities, I continue to believe in the long-term thesis for TRNS." A technician inspecting a complex instrument, relics of advanced technology in the backdrop. Transcat, Inc. (NASDAQ:TRNS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held Transcat, Inc. (NASDAQ:TRNS) at the end of the fourth quarter which was 10 in the previous quarter. In the fiscal third quarter of 2025, Transcat, Inc.'s (NASDAQ:TRNS) consolidated revenue was up 2% to $66.8 million however, organic revenue fell 4% from prior year quarter. While we acknowledge the potential of Transcat, Inc. (NASDAQ:TRNS) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. We covered Transcat, Inc. (NASDAQ:TRNS) in another article, where we shared Conestoga Capital Advisors' views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store